A randomized phase II neoadjuvant trial in patients with stage II-III and inflammatory breast cancer

被引：0
|
作者：
Somlo, G. [1 ]
Paz, B. [1 ]
Shen, J. [1 ]
Garberoglio, C. [1 ]
Luu, T. [1 ]
Chung, C. [1 ]
Hurria, A. [1 ]
Frankel, P. [1 ]
Baker, N. [1 ]
Wilczynski, S. [1 ]
Arnold, K. [1 ]
Yeb, Y. [1 ]
机构：
[1] City Hope Comprehens Canc Ctr, Duarte, CA USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S231 / S231
页数：1
相关论文
共 50 条
  • [21] Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
    Lin, Po-Han
    Wang, Ming-Yang
    Lo, Chiao
    Tsai, Li-Wei
    Yen, Tzu-Chun
    Huang, Thomas Yoyan
    Huang, Wei-Chih
    Yang, Karen
    Chen, Chih-Kai
    Fan, Sheng-Chih
    Kuo, Sung-Hsin
    Huang, Chiun-Sheng
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] Phase II Trial of Neoadjuvant Bevacizumab with Modified FOLFOX7 in Patients with Stage II and III Rectal Cancer
    Barzi, Afsaneh
    Choi, April
    Tsao-Wei, Denice
    Iqbal, Syma
    El-Khoueiry, Anthony
    Agafitei, Dana Raluca
    Cologne, Kyle G.
    Lenz, Heinz-Josef
    [J]. ONCOLOGIST, 2020, 25 (12): : E1879 - E1885
  • [23] Neoadjuvant trastuzumab and sequential chemotherapy with cisplatin, vinorelbine, and docetaxel for stage II-III breast cancer patients: Final results of a single institution phase II study.
    Carillio, Guido
    Aiello, Rosa Anna
    Chiarenza, Maurizio
    Ali, Marco
    Mazzola, Antonella
    Di Marco, Rosanna
    Taibi, Eleonora
    Fallica, Giuseppina
    Casella, Tiziana
    Zacchia, Alessandra
    Castiglione, Gaetano
    Caruso, Francesco
    Caruso, Michele
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Neoadjuvant immunotherapy and chemoimmunotherapy for stage II-III muscle invasive bladder cancer
    Chen, Hualin
    Yang, Wenjie
    Xue, Xiaoqiang
    Li, Yingjie
    Jin, Zhaoheng
    Ji, Zhigang
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [25] Multicenter study of nonpegylated liposomal doxorubicin and docetaxel as neoadjuvant treatment in patients with stage II-III breast
    Modolell, A
    Mayordomo, J
    Garcia, JM
    Machengs, I
    Alvarez, I
    Palombo, H
    Yubero, A
    Murillo, L
    Belon, J
    Andres, R
    Burillo, M
    Lambea, J
    Centelles, M
    Tres, A
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S226 - S226
  • [26] Gene expression panel (TheraPrint) analyzed as predictors of response to neoadjuvant chemotherapy (NCT) in patients (pts) with stage II-III and inflammatory breast cancer (BC).
    Somlo, George
    De Snoo, Femke
    Peeters, Justine
    Stork-Sloots, Lisette
    Simon, Iris
    Robinson, Kim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [27] Gene expression panel (TheraPrint) analyzed as predictors of response to neoadjuvant chemotherapy (NCT) in patients (pts) with stage II-III and inflammatory breast cancer (BC).
    De Snoo, Femke
    Peeters, Justine
    Robinson, Kim
    Stork-Sloots, Lisette
    Simon, Iris
    Somlo, George
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Surgical aspects of induction chemotherapy in stage II-III breast cancer
    Terribile, D
    Masetti, R
    Marra, A
    Antinori, A
    Valentini, M
    Margaritora, S
    Nardone, L
    Scapati, AM
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1043 - 1043
  • [29] Neoadjuvant chemotherapy in the treatment of stage II and III breast cancer
    Singletary, SE
    [J]. AMERICAN JOURNAL OF SURGERY, 2001, 182 (04): : 341 - 346
  • [30] Postmastectomy Radiation Therapy Improved Locoregional Control in Patients With Clinical Stage II-III Breast Cancer After Neoadjuvant Chemotherapy
    Cao, L.
    Chen, J.
    Xu, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E40 - E41
12345